FDA limits J&J COVID-19 vaccine due to rare blood clot risk Thursday, May 5 by ABC News(WASHINGTON) -- The U.S. Food and Drug Administration on Thursday announced it's now limiting the authorized use of the Johnson & Johnson vaccine after conducting an updated investigation into reports of rare blood clots.Though the risk of blood clots is still extremely rare, officials... Read More.